Clorox (CLX) Fundamentals Continue to Deteriorate, Morgan Stanley Reiterates Underweight
Tweet Send to a Friend
Morgan Stanley analyst Dara Mohsenian reiterated an Underweight rating and $144.00 price target on Clorox (NYSE: CLX) as fundamentals deteriorate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


